Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.11-68.1133.8294.6045.00

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is 2.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.11
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.11
Positive
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹90.7 Cr -7% 7.1% -39.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,032.0 Cr 0.9% 12.8% 4.6% Stock Analytics
DIVIS LABORATORIES ₹183,759.0 Cr 3.2% 14% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,224.0 Cr 0.7% 5.5% 36.9% Stock Analytics
CIPLA ₹116,214.0 Cr 6.8% 18.8% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹108,739.0 Cr 0.7% 5.5% 9.4% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-7%

7.1%

-39.3%

SENSEX

-3.1%

-2.8%

-6.1%


You may also like the below Video Courses